Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Amarin Jumps on Heart-Drug Progress in China Trial
By Tony Owusu
Nov 20, 2020 10:06 AM EST
PRESS RELEASES
Dr. Reddy's And GRA Announces Avigan Pivotal Studies Update
By Business Wire
Jan 27, 2021 5:02 AM EST
PRESS RELEASES
Dr. Reddy's Receives Approval To Conduct Phase 3 Clinical Trial For Sputnik V Vaccine In India
By Business Wire
Jan 15, 2021 12:33 PM EST
PRESS RELEASES
Sputnik V Meets The Primary Endpoint Of Safety In The Phase 2 Clinical Trial In India
By Business Wire
Jan 11, 2021 10:25 AM EST
PRESS RELEASES
Dr. Reddy's Laboratories, Global Response Aid, And Appili Therapeutics Announce The Filing Of An Application For REEQONUS™ (favipiravir) Tablets For The Treatment Of COVID-19 Under Health Canada's Interim Order
By Business Wire
Dec 22, 2020 1:11 AM EST
PRESS RELEASES
Secondary Listing Of Dr. Reddy's ADRs On NSE IFSC Limited (GIFT City, Gujarat, India)
By Business Wire
Dec 9, 2020 4:20 AM EST
PRESS RELEASES
Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India
By Business Wire
Dec 1, 2020 8:15 AM EST
PRESS RELEASES
Dr. Reddy's To Acquire Select Anti-Allergy Brands From Glenmark In Russia, Ukraine, Kazakhstan And Uzbekistan
By Business Wire
Nov 28, 2020 11:33 AM EST
INVESTING
Amarin Jumps on Heart-Drug Progress in China Trial
By Tony Owusu
Nov 20, 2020 10:06 AM EST
PRESS RELEASES
Dr. Reddy's Partners With Department Of Biotechnology - Biotechnology Industry Research Assistance Council For Sputnik V Vaccine Clinical Trials In India
By Business Wire
Oct 29, 2020 2:19 AM EDT
PRESS RELEASES
Dr. Reddy's Announces The Re-launch Of Over-the-counter Famotidine Tablets USP, 10 Mg And 20 Mg, Store-brand Equivalent Of Pepcid AC® In The U.S. Market
By Business Wire
Oct 20, 2020 3:44 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Joins Science Based Targets Initiative (SBTi) And Sets 2030 GHG Emission Targets
By Business Wire
Oct 5, 2020 5:27 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of A Generic Version Of Sapropterin Dihydrochloride Tablets For Oral Use In The U.S. Market
By Business Wire
Oct 3, 2020 2:57 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of Cinacalcet Tablets In The U.S. Market
By Business Wire
Oct 1, 2020 4:08 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of Dimethyl Fumarate Delayed-Release Capsules In The U.S. Market
By Business Wire
Sep 26, 2020 6:03 AM EDT
STOCKS
51Job, U.S. Steel, Sorrento: 5 Top Stock Gainers Thursday
By Rob Lenihan
Sep 17, 2020 4:22 PM EDT
PRESS RELEASES
RDIF And Dr. Reddy's To Cooperate On Clinical Trials And Supply Of 100 Million Doses Of Sputnik V Vaccine To India
By Business Wire
Sep 16, 2020 6:26 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of Fulvestrant Injection, 250 Mg/5 ML (50 Mg/mL) Per Single-Dose Syringe In The U.S. Market
By Business Wire
Sep 7, 2020 8:34 AM EDT
STOCKS
Amarin Loses Appeal in Heart Treatment Patent Case
By Rob Lenihan
Sep 3, 2020 12:00 PM EDT
INVESTING
Amarin Shares Off - Analysts Mull Prospects of Patent-Case Appeal
By Rob Lenihan
Sep 2, 2020 3:15 PM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of AVIGAN® (Favipiravir) In India
By Business Wire
Aug 19, 2020 4:17 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of Over-The-Counter Nicotine Polacrilex Lozenges, 2 Mg And 4 Mg, The Store Brand Version Of Nicorette® Lozenges In The U.S. Market
By Business Wire
Jul 14, 2020 4:45 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Announces The Launch Of Abiraterone Acetate Tablets USP, 250 Mg In The U.S. Market
By Business Wire
Jun 19, 2020 5:39 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Limited Announces Filing Of Annual Report On Form 20-F
By Business Wire
Jun 16, 2020 1:48 AM EDT
PRESS RELEASES
Dr. Reddy's Laboratories Enters Into A Licensing Agreement With Gilead Sciences For Remdesivir
By Business Wire
Jun 13, 2020 5:15 AM EDT
